Science Explorer Back to mapMap
Discussion

Tetra Therapeutics (United States)

Research works
15
▼ 85% vs 2018-21
Citations
611
39.9 per fractional work
Top-10% rate
5.7%
all institutions 10.0%
Open access
77%
world 40%
International
22%
world 18%

Not ranked overall: Tetra Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Tetra Therapeutics (United States) work in?

In all years, 47% of research at Tetra Therapeutics (United States) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (27%), Economics, Econometrics and Finance (4%). It does 1.6× the world's share of Life Sciences.

Health Sciences: 7 fractional works · 46.7% of its workMedicine: 7 fractional works · 46.7% of its workSurgery: 2 fractional works · 10.4% of its workPharmacology: 1 fractional works · 9.6% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 4.9% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 4.7% of its workPhysiology: 1 fractional works · 3.6% of its workEpidemiology: 1 fractional works · 3.5% of its workNeurology: 0 fractional works · 1.8% of its workOncology: 0 fractional works · 1.6% of its workInfectious Diseases: 0 fractional works · 1.4% of its workTransplantation: 0 fractional works · 1.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.1% of its workRheumatology: 0 fractional works · 0.9% of its workOphthalmology: 0 fractional works · 0.7% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.7% of its workLife Sciences: 6 fractional works · 36.0% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 27.4% of its workMolecular Biology: 4 fractional works · 23.1% of its workGenetics: 0 fractional works · 2.6% of its workCell Biology: 0 fractional works · 0.5% of its workEndocrinology: 0 fractional works · 0.5% of its workBiochemistry: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.4% of its workNeuroscience: 1 fractional works · 3.9% of its workCognitive Neuroscience: 0 fractional works · 2.3% of its workNeurology: 0 fractional works · 1.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 2.2% of its workPlant Science: 0 fractional works · 1.4% of its workSoil Science: 0 fractional works · 0.7% of its workImmunology and Microbiology: 0 fractional works · 1.4% of its workImmunology: 0 fractional works · 1.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.1% of its workPharmacology: 0 fractional works · 1.1% of its workSocial Sciences: 2 fractional works · 13.8% of its workEconomics, Econometrics and Finance: 1 fractional works · 4.4% of its workEconomics and Econometrics: 1 fractional works · 4.4% of its workBusiness, Management and Accounting: 1 fractional works · 4.0% of its workAccounting: 0 fractional works · 2.2% of its workStrategy and Management: 0 fractional works · 1.8% of its workSocial Sciences: 1 fractional works · 3.7% of its workLaw: 0 fractional works · 2.5% of its workHealth: 0 fractional works · 1.1% of its workPsychology: 0 fractional works · 1.8% of its workExperimental and Cognitive Psychology: 0 fractional works · 1.2% of its workClinical Psychology: 0 fractional works · 0.7% of its workPhysical Sciences: 1 fractional works · 3.5% of its workChemistry: 0 fractional works · 2.2% of its workOrganic Chemistry: 0 fractional works · 2.2% of its workEnvironmental Science: 0 fractional works · 1.3% of its workEcology: 0 fractional works · 0.8% of its workGlobal and Planetary Change: 0 fractional works · 0.5% of its workALL ITS WORKTetraTherapeutics…15fractional works, all years
Life Sciences36%Physical Sciences3%Health Sciences47%Social Sciences14%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine746.7%
    1. Biochemistry, Genetics and Molecular Biology427.4%
    2. Neuroscience13.9%
    3. Agricultural and Biological Sciences02.2%
    4. Immunology and Microbiology01.4%
    5. Pharmacology, Toxicology and Pharmaceutics01.1%
    1. Economics, Econometrics and Finance14.4%
    2. Business, Management and Accounting14.0%
    3. Social Sciences13.7%
    4. Psychology01.8%
    1. Chemistry02.2%
    2. Environmental Science01.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 4.48× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.39× its world share, 0 worksBiochemistry, Geneti…Neuroscience: 4.81× its world share, 0 worksNeuroscienceMedicine: 0.59× its world share, 0 worksMedicineBusiness, Management and Accounting: 6.60× its world share, 0 worksBusiness, Management…Psychology: 1.40× its world share, 0 worksPsychologySocial Sciences: 0.84× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Business, Management and Accounting, 6.6×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Business, Management and Accounting6.60×0 works
  2. Neuroscience4.81×0 works
  3. Agricultural and Biological Sciences4.48×0 works
  4. Biochemistry, Genetics and Molecular Biology4.39×0 works
  5. Psychology1.40×0 works
  6. Social Sciences0.84×0 works
  7. Medicine0.59×0 works

Who are the top researchers at Tetra Therapeutics (United States)?

Ranked on the quality score, Mark E. Gurney lead among researchers whose main affiliation is Tetra Therapeutics (United States).

  1. 1 Mark E. Gurney United States · #86,382 worldwide 9.1k citations · 92 works
All ranked researchers at Tetra Therapeutics (United States)

What are the most cited papers from Tetra Therapeutics (United States)?

The most cited paper from Tetra Therapeutics (United States) is "COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US" (QuanQiu Wang, Pamela B. Davis, Mark E. Gurney et al., 2021), with 275 citations. Next come "Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis" (156) and "Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial" (135).

Most cited papers
#PaperReleasedCitations
1 COVID‐19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US QuanQiu Wang, Pamela B. Davis, Mark E. Gurney et al. · Alzheimer s & Dementia Open access 9 Feb 2021 275
2 Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis Mengshi Zhou, Rong Xu, David C. Kaelber et al. · PLoS ONE Open access 23 Mar 2020 156
3 Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial Elizabeth Berry‐Kravis, Mark D. Harnett, Scott A. Reines et al. · Nature Medicine 29 Apr 2021 135
4 Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer's Disease Mark E. Gurney, Emily C. D’Amato, Alex B. Burgin · Neurotherapeutics Open access 4 Nov 2014 119
5 Structural basis for the design of selective phosphodiesterase 4B inhibitors David N. A. Fox, Alex B. Burgin, Mark E. Gurney · Cellular Signalling Open access 19 Dec 2013 104
All 31 most cited papers, with filters and sorting

Which research topics does Tetra Therapeutics (United States) publish most on?

By volume in 2022-now: Legal Issues in South Africa, Corporate Taxation and Avoidance, Taxation and Legal Issues and Cognitive Functions and Memory.

  1. 1 Legal Issues in South Africa Law 0 works
  2. 2 Corporate Taxation and Avoidance Accounting 0 works
  3. 3 Taxation and Legal Issues Accounting 0 works
  4. 4 Cognitive Functions and Memory Experimental and Cognitive Psychology 0 works
  5. 5 melanin and skin pigmentation Cell Biology 0 works
  6. 6 Plant Micronutrient Interactions and Effects Plant Science 0 works
  7. 7 Mycobacterium research and diagnosis Epidemiology 0 works
  8. 8 Seed Germination and Physiology Plant Science 0 works
  9. 9 Autism Spectrum Disorder Research Cognitive Neuroscience 0 works
  10. 10 Genetics and Neurodevelopmental Disorders Genetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available77.3%not open22.7%

World: 40% of research is openly available.

with international co-authors22.2%domestic only77.8%

World: 18% is written across borders.

How has Tetra Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 85% lower than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Tetra Therapeutics (United States) as a percentage of every work published that year, 0.0000090% in 2024.

still counting0.000025%0.000050%0.000075%Tetra Therapeutics (United States)0.0000097% in 202520102020

Fractional works of Tetra Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Grand Rapids

All research institutions in Grand Rapids

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Tetra Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.